Skip to main
LDOS

Leidos Hld (LDOS) Stock Forecast & Price Target

Leidos Hld (LDOS) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 55%
Buy 27%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Leidos Holdings Inc. has demonstrated strong financial performance, particularly within its Health & Civil segment, where increased exam volumes have significantly driven margins. The company reported a notable 8% year-over-year growth in National Security revenues, reaching $2.02 billion, fueled by recent contract awards and growth in defense IT/mission support. Furthermore, the improvement in EBIT margins from 14.5% in 2023 to an anticipated 24.3% in the first half of 2025 underscores the company's operational efficiency and profitability trajectory.

Bears say

Leidos Holdings Inc. is experiencing a forecasted decline in margins, particularly anticipated in the second half of 2025 compared to the first half, raising concerns about long-term profitability. The company's higher-margin managed health services segment may also face further year-over-year declines due to increased competition, which presents a considerable risk to overall margins if medical exam volumes decrease significantly. Additionally, external factors such as protests against large contract wins, uncertainties in defense spending, potential government shutdowns, and regulatory risks tied to international operations further exacerbate the negative outlook on the stock.

Leidos Hld (LDOS) has been analyzed by 11 analysts, with a consensus rating of Buy. 55% of analysts recommend a Strong Buy, 27% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Leidos Hld (LDOS) Forecast

Analysts have given Leidos Hld (LDOS) a Buy based on their latest research and market trends.

According to 11 analysts, Leidos Hld (LDOS) has a Buy consensus rating as of Dec 29, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $207.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $207.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Leidos Hld (LDOS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.